Showing results (191-200 of 406) with videos related to
Sort By:
Pageof 41
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 6, 2014
Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomasMelike Pekmezci, David E Reuss, Angela C Hirbe, et al.Brain Pathology (Zurich, Switzerland)|April 22, 2008
Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomasSushama Patil, Arie Perry, Mia Maccollin, et al.Journal of Neuropathology and Experimental Neurology|August 3, 2002
Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasmsArie Perry, Sarah N Kunz, Christine E Fuller, et al.Journal of Neuro-Oncology|August 29, 2018
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastomaJennie W Taylor, Mili Parikh, Joanna J Phillips, et al.The Science of the Total Environment|September 11, 2024
Exposure to acute ambient temperature extremes and neonatal intensive care unit admissions: A case-crossover studySarah LaPointe, Jing Nie, Danielle R Stevens, et al.Neuro-Oncology Advances|October 30, 2023
Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effectDavid Gibson, Akshay Ravi, Eduardo Rodriguez, et al.Endocrine Pathology|October 11, 2017
Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell AdenomasJulieann C Lee, Melike Pekmezci, Jonathan L Lavezo, et al.Human Pathology|December 3, 2014
Low-grade small round cell tumor of the cauda equina with EWSR1-WT1 fusion and indolent clinical courseNasir Ud Din, Melike Pekmezci, Gohar Javed, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2026
Stratification by Ki-67 Labeling Index Increases Specificity of p16INK4a Expression as a Surrogate Marker for CDKN2A Inactivation in MeningiomaKevin Y Zhang, Kanish Mirchia, Arie Perry, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|March 3, 2016
Gliosarcomas lack BRAFV600E mutation, but a subset exhibit β-catenin nuclear localizationKatherine E Schwetye, Nancy M Joseph, Hussam Al-Kateb, et al.Pageof 41